Biomarker testing in non-small cell lung cancer in routine care: Analysis of the first 3,717 patients in the German prospective, observational, nation-wide CRISP Registry (AIO-TRK-0315)

•The CRISP registry collects representative, nationwide data on NSCLC in Germany.•CRISP mirrors the treatment and disease trajectory of patients with advanced NSCLC.•Biomarker testing rates increased over time, yet are still improvable.•17.7 % of the patients presented with a druggable alteration.•M...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Lung cancer (Amsterdam, Netherlands) Netherlands), 2021-02, Vol.152, p.174-184
Hauptverfasser:	Griesinger, Frank, Eberhardt, Wilfried, Nusch, Arnd, Reiser, Marcel, Zahn, Mark-Oliver, Maintz, Christoph, Bernhardt, Christiane, Losem, Christoph, Stenzinger, Albrecht, Heukamp, Lukas C., Büttner, Reinhard, Marschner, Norbert, Jänicke, Martina, Fleitz, Annette, Spring, Lisa, Sahlmann, Jörg, Karatas, Aysun, Hipper, Annette, Weichert, Wilko, Heilmann, Monika, Sadjadian, Parvis, Gleiber, Wolfgang, Grah, Christian, Waller, Cornelius F., Reck, Martin, Rittmeyer, Achim, Christopoulos, Petros, Sebastian, Martin, Thomas, Michael
Format:	Artikel
Sprache:	eng
Schlagworte:	Biomarkers Biomarkers, Tumor Carcinoma, Non-Small-Cell Lung - diagnosis Carcinoma, Non-Small-Cell Lung - genetics Cohort studies Germany - epidemiology Humans Lung Neoplasms - diagnosis Lung Neoplasms - epidemiology Lung Neoplasms - genetics Molecular diagnostic testing Mutation Non-small cell lung cancer Prospective Studies Registries
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!